Morphological and quantitative assessment of mast cells in rheumatoid arthritis associated non-specific interstitial pneumonia and usual interstitial pneumonia

被引:9
作者
Atkins, SR
Matteson, EL
Myers, JL
Ryu, JH
Bongartz, T
机构
[1] Mayo Clin & Mayo Fdn, Coll Med, Div Rheumatol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Coll Med, Dept Pathol, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Coll Med, Div Pulm & Crit Care Med, Rochester, MN 55905 USA
关键词
D O I
10.1136/ard.2005.043877
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The role of mast cells in extra-articular manifestations of rheumatoid arthritis ( RA) has not been studied so far. Objective: To characterise and quantify mast cells in RA associated interstitial pneumonia (IP) by an immunohistological study. Methods: Lung biopsy specimens from 15 patients with RA associated IP, 12 patients with idiopathic IP, and 5 control patients were stained with antibodies directed against tryptase ( mast cell marker). Morphological characterisation of stained specimens was carried out and staining was quantified by computer assisted image analysis. Results: Tryptase staining showed the marked presence of mast cells in idiopathic IP and in RA associated IP. A significant difference in stained tissue area was found between RA associated IP (2.6%, IQR 2.0 - 3.2%, p = 0.015) and idiopathic IP (3.1%, IQR 1.8 - 3.7%, p = 0.003) compared with control tissue specimens (1.0%, IQR 0.7 - 1.5%). The extent of mast cell infiltration correlated well and inversely with pulmonary function variables. Conclusions: Mast cell infiltrates are present in RA associated IP and idiopathic IP. The observed correlation of pulmonary function and mast cell numbers would be consistent with the proposed role of mast cell mediators in the promotion of fibrogenesis. The findings provide a rationale for studying functional aspects of mast cell involvement in the pathogenesis of RA associated lung disease.
引用
收藏
页码:677 / 680
页数:4
相关论文
共 16 条
[1]   Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2 [J].
Akers, IA ;
Parsons, M ;
Hill, MR ;
Hollenberg, MD ;
Sanjar, S ;
Laurent, GJ ;
McAnulty, RJ .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2000, 278 (01) :L193-L201
[2]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[3]   CELLS, COLLAGEN AND IDIOPATHIC PULMONARY FIBROSIS [J].
CRYSTAL, RG ;
FULMER, JD ;
BAUM, BJ ;
BERNARDO, J ;
BRADLEY, KH ;
BRUEL, SD ;
ELSON, NA ;
FELLS, GA ;
FERRANS, VJ ;
GADEK, JE ;
HUNNINGHAKE, GW ;
KAWANAMI, O ;
KELMAN, JA ;
LINE, BR ;
MCDONALD, JA ;
MCLEES, BD ;
ROBERTS, WC ;
ROSENBERG, DM ;
TOLSTOSHEV, P ;
VONGAL, E ;
WEINBERGER, SE .
LUNG, 1978, 155 (03) :199-224
[4]  
DAVIDSON S, 1983, IMMUNOLOGY, V48, P439
[5]   IMMUNOFLUORESCENT STAINING FOR MAST-CELLS IN IDIOPATHIC PULMONARY FIBROSIS - QUANTIFICATION AND EVIDENCE FOR EXTRACELLULAR RELEASE OF MAST-CELL TRYPTASE [J].
HUNT, LW ;
COLBY, TV ;
WEILER, DA ;
SUR, S ;
BUTTERFIELD, JH .
MAYO CLINIC PROCEEDINGS, 1992, 67 (10) :941-948
[6]   Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis [J].
Inoue, Y ;
King, TE ;
Barker, E ;
Daniloff, E ;
Newman, LS .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (05) :765-773
[7]   Mast cells: A cellular link between autoantibodies and inflammatory arthritis [J].
Lee, DM ;
Friend, DS ;
Gurish, MF ;
Benoist, C ;
Mathis, D ;
Brenner, MB .
SCIENCE, 2002, 297 (5587) :1689-1692
[8]  
LEVISCHAFFER F, 1987, J IMMUNOL, V139, P3431
[9]  
LEVISCHAFFER F, 1985, J IMMUNOL, V135, P3454
[10]   A specific chymase inhibitor, NK3201, suppresses bleomycin-induced pulmonary fibrosis in hamsters [J].
Sakaguchi, M ;
Takai, S ;
Jin, D ;
Okamoto, Y ;
Muramatsu, M ;
Kim, S ;
Miyazaki, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 493 (1-3) :173-176